Cognitive outcomes after tadalafil treatment in patients with cerebral small vessel disease: ETLAS-2 sub-study

Background: Cerebral small vessel disease (CSVD) is the dominant cause of vascular cognitive impairment and dementia. We aimed to test whether continuous daily treatment with the vasoactive phosphodiesterase 5 inhibitor tadalafil improved cognitive performance in patients with CSVD. Methods: This is...

Descripció completa

Dades bibliogràfiques

Autors principals:	Joakim Ölmestig, Kristian N. Mortensen, Marie B. Thomas, Birgitte Fagerlund, Trevor W. Robbins, Nadia Naveed, Mette M. Nordling, Hanne Christensen, Helle K. Iversen, Mai B. Poulsen, Hartwig R. Siebner, Christina Kruuse
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-01-01
Col·lecció:	Cerebral Circulation - Cognition and Behavior
Matèries:	CANTAB MoCA SDMT Trail-making test A and B Digit span Verbal fluency
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666245025001448
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!